Central Drugs Standard Control Organization (cdsco) - Pharma

Relevant Publications

A review on the pharmacology of cariprazine and its role in the treatment of negative symptoms of schizophrenia.

Issue Release: 2024

The Dawn till Dusk of phytopharmaceuticals.

Issue Release: 2024

A Real-World Study of Safety, Immunogenicity and Efficacy of Bevacizumab in Patients With Solid Malignancies: A Phase IV, Post-Marketing Study in India.

Issue Release: 2023

NANOTEX BONE Graft along with Fibula Flap in the Reconstruction of Segmental Mandibular Defect: Protocol for Pilot Clinical Trial.

Issue Release: 2023

Investigator knowledge, awareness, and registrations of academic clinical trials with the Clinical Trial Registry of India: An observational study.

Issue Release: 2023

Future of TABST and LABST in the Indian Pharmacopoeia Monographs A Humane Society International/India Workshop Report.

Issue Release: 2023

Development of Pharmacovigilance System in India and paradigm of pharmacovigilance research: an overview.

Issue Release: 2022

Assessment of safety and adverse drug reactions of COVID vaccination in the South Indian population: An observational prospective cross-sectional study.

Issue Release: 2022

A comparative study of cancer drug approvals in india and high-income countries.

Issue Release: 2022

An evaluation of drug lag for new drugs approved by the Indian regulator relative to the United States, European Union, and Japanese regulatory agencies: A 15-year analysis (2004-2018).

Issue Release: 2021

Study of COVID-19 Infection, its Severity and Outcome in COVID-19 Vaccinated People at Tertiary Health Care Center, North West Rajasthan.

Issue Release: 2021

Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants.

Issue Release: 2021

Terror of 10 MB, a cross-sectional study investigates the regulation to the prospective of medical device.

Issue Release: 2020

Chitra Ultraviolet-C-Based Facemask Disposal Bin.

Issue Release: 2020

Fixed dose combinations of anti-tubercular, antimalarial and antiretroviral medicines on the Indian market: critical analysis of ubiquity, sales and regulatory status.

Issue Release: 2018

Adequacy of clinical trial evidence of metformin fixed-dose combinations for the treatment of type 2 diabetes mellitus in India.

Issue Release: 2018

Antecedent Drug Exposure Aetiology and Management Protocols in Steven-Johnson Syndrome and Toxic Epidermal Necrolysis, A Hospital Based Prospective Study.

Issue Release: 2016

Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs.

Issue Release: 2015

Comparative regulatory performance on introduction & withdrawal of drugs in India and EU/internationally.

Issue Release: 2013

An audit of minutes of Subject Expert Committee meetings as a metric to assess the clinical research roadmap of India.

Issue Release: 0000

Why is Medication Adherence Important?

How Are Participants Protected?

What are the Challenges Faced by Generic Manufacturers?

What is Geriatric Care in Pharma?

Why do Pharma Companies Use CROs?

What Challenges Exist in Patient Education?

How are ADEs Different from Side Effects?

What is the Future of ADE Management?

What are the Key Challenges?

What is Pharmaceutical Science?

Central Drugs Standard Control Organization (cdsco) - Pharma

Relevant Publications

Partnered Content Networks

Relevant Topics